Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0J4PM
|
|||
| Former ID |
DIB009531
|
|||
| Drug Name |
NNC-0151-0000-0000
|
|||
| Synonyms |
Neutrazumab; Anti-C5aR monoclonal antibodies (rheumatoid arthritis/SLE), G2/Novo Nordisk
Click to Show/Hide
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Rheumatoid arthritis [ICD-11: FA20] | Phase 2 | [1] | |
| Company |
G2 Therapies Ltd
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Complement-targeted therapeutics. Nat Biotechnol. 2007 Nov;25(11):1265-75. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.